22 05, 2024 Impact of Omicron BA.1 infection on BA.4/5 immunity in transplant recipients Neal Evan Caminsky2024-05-22T14:50:21-04:00May 22, 2024|Funded Research Results, Pillar 4|
22 05, 2024 SARS-CoV-2 virus-like particle neutralizing capacity in blood donors depends on serological profile and donor-declared SARS-CoV-2 vaccination history Neal Evan Caminsky2024-05-22T10:26:15-04:00May 22, 2024|Funded Research Results, Pillar 4|
21 05, 2024 Neutralisation against Omicron variant in transplant recipients after three doses of mRNA vaccine Neal Evan Caminsky2024-05-21T16:49:25-04:00May 21, 2024|Funded Research Results, Pillar 4|
21 05, 2024 Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings Neal Evan Caminsky2024-05-21T14:35:38-04:00May 21, 2024|Funded Research Results, Pillar 4|
16 05, 2024 Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B Neal Evan Caminsky2024-05-16T09:19:07-04:00May 16, 2024|Funded Research Results, Pillar 4|
13 05, 2024 Germicidal efficacy of continuous and pulsed ultraviolet-C radiation on pathogen models and SARS-CoV-2 Neal Evan Caminsky2024-05-13T10:02:41-04:00May 13, 2024|Funded Research Results, Pillar 3|
2 05, 2024 Thiopurines inhibit coronavirus Spike protein processing and incorporation into progeny virions Neal Evan Caminsky2024-05-02T15:52:12-04:00May 2, 2024|Funded Research Results, Pillar 3|
11 04, 2024 A universal sequencing read interpreter Neal Evan Caminsky2024-04-11T12:23:38-04:00April 11, 2024|Funded Research Results, Pillar 4|
11 04, 2024 A multi-kingdom genetic barcoding system for precise target clone isolation Neal Evan Caminsky2024-04-11T12:22:30-04:00April 11, 2024|Funded Research Results, Pillar 4|
26 03, 2024 Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals Neal Evan Caminsky2024-03-26T15:02:33-04:00March 26, 2024|Funded Research Results, Pillar 10|